Antiandrogen (Indonesian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Antiandrogen" in Indonesian language version.
refsWebsite
Global rank
Indonesian rank
6th place
2nd place
archive.org
- Nath JL (2006). Using Medical Terminology: A Practical Approach
. Lippincott Williams & Wilkins. hlm. 977–. ISBN 978-0-7817-4868-1. - Schröder FH, Radlmaier A (2009). "Steroidal Antiandrogens". Dalam Jordan VC, Furr BA. Hormone Therapy in Breast and Prostate Cancer. Humana Press. hlm. 325–346. doi:10.1007/978-1-59259-152-7_15. ISBN 978-1-60761-471-5.
- Kolvenbag GJ, Furr BJ (2009). "Nonsteroidal Antiandrogens". Dalam Jordan VC, Furr BJ. Hormone Therapy in Breast and Prostate Cancer. Humana Press. hlm. 347–368. doi:10.1007/978-1-59259-152-7_16. ISBN 978-1-60761-471-5.
doi.org
- Brueggemeier RW (2006). "Sex Hormones (Male): Analogs and Antagonists". Encyclopedia of Molecular Cell Biology and Molecular Medicine. doi:10.1002/3527600906.mcb.200500066. ISBN 3527600906.
- Student S, Hejmo T, Poterała-Hejmo A, Leśniak A, Bułdak R (January 2020). "Anti-androgen hormonal therapy for cancer and other diseases". Eur. J. Pharmacol. 866: 172783. doi:10.1016/j.ejphar.2019.172783. PMID 31712062.
- Gillatt D (2006). "Antiandrogen treatments in locally advanced prostate cancer: are they all the same?". J Cancer Res Clin Oncol. 1: S17–26. doi:10.1007/s00432-006-0133-5. PMID 16845534.
- Lieberman R (2001). "Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development". Urology. 58 (2 Suppl 1): 83–90. doi:10.1016/s0090-4295(01)01247-x. PMID 11502457.
There are several classes of antiandrogens including (1) antigonadotropins (eg, LHRH agonists/antagonists, synthetic estrogens [diethylstilbestrol]); (2) nonsteroidal androgen-receptor antagonists (eg, flutamide, bicalutamide, nilutamide); (3) steroidal agents with mixed actions (eg, cyproterone acetate); (4) adrenal androgen inhibitors (eg, ketoconazole, hydrocortisone); (5) steroidal agents that inhibit androgen biosynthesis (eg, 5α-reductase inhibitors (type II) and dual-acting 5α-reductase inhibitors); [...]
- Schröder FH, Radlmaier A (2009). "Steroidal Antiandrogens". Dalam Jordan VC, Furr BA. Hormone Therapy in Breast and Prostate Cancer. Humana Press. hlm. 325–346. doi:10.1007/978-1-59259-152-7_15. ISBN 978-1-60761-471-5.
- Kolvenbag GJ, Furr BJ (2009). "Nonsteroidal Antiandrogens". Dalam Jordan VC, Furr BJ. Hormone Therapy in Breast and Prostate Cancer. Humana Press. hlm. 347–368. doi:10.1007/978-1-59259-152-7_16. ISBN 978-1-60761-471-5.
nih.gov
ncbi.nlm.nih.gov
- Mowszowicz I (1989). "Antiandrogens. Mechanisms and paradoxical effects". Ann. Endocrinol. Paris. 50 (3): 50(3):189–99. PMID 2530930.
- Student S, Hejmo T, Poterała-Hejmo A, Leśniak A, Bułdak R (January 2020). "Anti-androgen hormonal therapy for cancer and other diseases". Eur. J. Pharmacol. 866: 172783. doi:10.1016/j.ejphar.2019.172783. PMID 31712062.
- Gillatt D (2006). "Antiandrogen treatments in locally advanced prostate cancer: are they all the same?". J Cancer Res Clin Oncol. 1: S17–26. doi:10.1007/s00432-006-0133-5. PMID 16845534.
- Lieberman R (2001). "Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development". Urology. 58 (2 Suppl 1): 83–90. doi:10.1016/s0090-4295(01)01247-x. PMID 11502457.
There are several classes of antiandrogens including (1) antigonadotropins (eg, LHRH agonists/antagonists, synthetic estrogens [diethylstilbestrol]); (2) nonsteroidal androgen-receptor antagonists (eg, flutamide, bicalutamide, nilutamide); (3) steroidal agents with mixed actions (eg, cyproterone acetate); (4) adrenal androgen inhibitors (eg, ketoconazole, hydrocortisone); (5) steroidal agents that inhibit androgen biosynthesis (eg, 5α-reductase inhibitors (type II) and dual-acting 5α-reductase inhibitors); [...]